UnitedHealth Group (UNH)

UnitedHealth stock tanks as CEO announces resignation and company pulls guidance.

Shares of UnitedHealth (UNH) have been in a steep decline. There is a chance the selloff may soon come to an end.

Shares of health insurance company UnitedHealth (NYSE:UNH) fell 16% in the afternoon session after the company announced the unexpected departure of its CEO, Andrew Witty, for personal reasons, leading to uncertainty in leadership as former CEO Stephen Hemsley returns. Also, it suspended its full-year 2025 financial outlook, citing a continued acceleration in care activity and higher-than-anticipated medical costs, particularly within its Medicare Advantage plans.

Wall Street's rally stretched into a second session Tuesday, fueled by improving investor sentiment after an early-week breakthrough in U.S.-China trade talks, easing inflation data and fresh geopolitical headlines involving major investment pledges from the Middle East.

Bernie Sanders wonders if Trump is "serious about making real change rather than just issuing a press release."

UnitedHealth Group shares plunged in premarket trading as the firm announced a surprise exit of the current CEO and pulled its full-year forecast.

U.S. stocks edged higher as April inflation cooled more than expected. Nasdaq 100 surged, led by semis and financials.

Consumer price index (CPI) rose 0.2% on a seasonally adjusted basis in April and increased 2.3% annually.

Cox Automotive executive analyst Erin Keating said that the cost of new cars has been climbing steadily since President Trump announced auto tariffs.

UnitedHealth CEO Andrew Witty resigns immediately; Stephen Hemsley returns as CEO and chairman as 2025 outlook is suspended due to rising costs.

UnitedHealth Stock: The Dow Jones giant warned again on medical costs and said its CEO is leaving. UNH stock plunged.

The company appointed Stephen J. Hemsley as its new chief executive officer, effective immediately.

The consumer price index is expected to remain at 2.4% in April year-over-year, with core inflation at 2.8%.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 13%. This performance was worse than the S&P 500’s 5.5% fall.

The proposal, citing a "Most Favored Nation Policy," fueled debate prompted some watchers to question the legality and feasibility of the move, while others speculated on its potential market impact.

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

Shareholders of UnitedHealth filed a class-action lawsuit on Wednesday accusing the company of misleading investors by concealing the negative business impacts that followed the December 2024 killing of UnitedHealthcare CEO Brian Thompson.